16:01:53 RRSAgent has joined #hcls 16:01:53 logging to http://www.w3.org/2013/11/12-hcls-irc 16:02:01 Zakim, this is COI 16:02:01 sorry, ericP, I do not see a conference named 'COI' in progress or scheduled at this time 16:02:07 Zakim, this is hcls 16:02:07 ok, ericP; that matches SW_HCLS()11:00AM 16:02:13 Zakim, who is here? 16:02:13 On the phone I see Kerstin_Forsberg, stevebattle7, +1.413.442.aaaa, +1.832.726.aabb 16:02:15 On IRC I see RRSAgent, Zakim, Josh, achille_zappa, deborah, TallTed, egonw__, ericP 16:02:42 Sajjad__INSERM_ has joined #hcls 16:03:04 + +33.1.73.71.aacc 16:03:17 +??P9 16:03:33 Sivaram has joined #HCLS 16:03:46 Zakim, ??P9 is Sajjad 16:03:46 +Sajjad; got it 16:03:55 + +31.62.427.aadd 16:03:59 charlie has joined #HCLS 16:04:21 Zakim, aadd is mscottm 16:04:21 +mscottm; got it 16:04:29 Zakim, who is here? 16:04:29 On the phone I see Kerstin_Forsberg, stevebattle7, +1.413.442.aaaa, +1.832.726.aabb, +33.1.73.71.aacc, Sajjad, mscottm 16:04:31 On IRC I see charlie, Sivaram, Sajjad__INSERM_, RRSAgent, Zakim, Josh, achille_zappa, deborah, TallTed, egonw__, ericP 16:04:36 mscottm has joined #hcls 16:04:48 Zakim, aaaa is Josh 16:04:48 +Josh; got it 16:05:06 Zakim, who is on the phone? 16:05:06 On the phone I see Kerstin_Forsberg, stevebattle7, Josh, +1.832.726.aabb, +33.1.73.71.aacc, Sajjad, mscottm 16:05:35 Deborah_ has joined #hcls 16:06:09 topic: Disease Ontology 16:07:21 ericP: Ontology mapping from, for example, SNOMED to LOINC is problematic and it is difficult to reuse the mapping. 16:07:59 + +1.650.433.aaee 16:08:14 .. at Emory wanted to map from SNOMED to other ontologies. 16:08:15 +Mike_Denny 16:09:15 650.433.aaee is Deborah_McGuinness 16:10:24 does anyone know who the contact is for the 12 therapeutic areas at ibm? 16:10:32 ..FDA has contracted IBM to model 12 therapeutic areas in RDF. 16:11:22 ericP and Charlie: We have been bugging the FDA about that for a while and it seems to have worked. 16:13:15 charlie: IBM has contracted to 2 small companies to do the work, which only started yesterday. 16:14:16 Deborah is interested in staying up to date and seeing early versions of the therapeutic models 16:15:41 charlie: in feb, they were talking about using BRIDG and the ISO21090 (Healthcare data types) 16:16:18 diabetes, clinical issues, disease ontology (based on snomed), and xx 16:16:39 ericP: Disease ontology that Emory wants to do is based on SNOMED 16:17:04 sivaram: what is the goal? 16:17:24 Sivaram: how does it differ from SNOMED disease areas? 16:17:29 goal: have summary level data for use in clinical trials 16:17:50 charlie: FDA's goal is to provide summary level data for trials 16:19:42 charlie: summary data in SDTM uses MedDra but the FDA feels that the data isn't granular / specific enough to do the types of analysis that they want to do. 16:20:27 Like to see some examples of the inadequacy of it 16:20:54 and what they expect to see from the proposed new model 16:20:59 charlie: they didn't feel that they could handle the volume of data from thousands of studies and patients 16:22:13 does someone have a link for that description? 16:24:00 ..When they first announced, number of areas was 55, went up too 65 areas, IBM has been contracted for 12 areas. 16:24:07 Kerstin has joined #hcls 16:25:29 Deborah: Are there any areas still to be contracted? 16:25:48 Sivaram: do they have examples of what they want to do? 16:26:04 Charlie: All the contracts are spoken for and have come through Duke and XXXX. 16:26:27 ... on the CDISC site, looking at the TAs you see a data model 16:27:07 i see http://www.cdisc.org/therapeutic but i do not see a full list of the 65 areas or the first 12 for modeling in rdf 16:29:13 Sivaram: If you're looking at the disease model, you're looking at many different aspects, such as biochemical aspects, pathways, etc. (doesn't understand motivation for a 'data model' for disease) 16:30:20 Sivaram: Have to watch out for conflation of the various models. 16:31:24 If I correctly followed the discussion so far, it is about the summary data model; as compared to medical domain of the therapeutic disease. For example, a data model used to report ICSR forms to FDA is E2B(R2) http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2B/Step4/E2B_R2__Guideline.pdf 16:32:04 Charlie: BRIDG and SNOMED can provide the context for some terms. 16:33:45 Eric: Suspect that many of the elements will connect and it will work out while working in RDF. 16:37:29 Sivaram: Does this fall into the category of ADAM? 16:38:44 Charlie: You would have to ask FDA that. Seems to, yes. 16:41:02 Eric: What are your favorite disease ontologies? 16:41:18 SNOMED for its coverage 16:42:46 SNOMED refsets 16:43:04 Deborah: People who use Epic, like folks at Mt. Sinai, use templates, sort of light-weight ontologies. 16:43:41 Intelligent Medical Objects 16:43:54 s/ADAM/ADaM/g 16:44:32 -Kerstin_Forsberg 16:45:26 -Josh 16:45:41 http://www.imbi.uni-freiburg.de/~schober/DCO/ 16:45:54 http://www.debugit.eu/ 16:45:58 Sajjad: What is the purpose of the disease ontologies? 16:46:00 +Josh 16:46:33 mscottm: used Human Disease Ontology 16:46:53 ... now mapping between NCIt and SNOMED 16:47:08 http://www.imbi.uni-freiburg.de/~schober/dco_owlDoc/ 16:47:15 Eric: My guess is that they are used to fill in CRF. (Charlie confirms) 16:47:35 lol 16:47:42 deborah: was going to start with the SNOMED. 16:48:32 Sivaram: looking at Phase I,II, SNOMED will cover a lot from a breadth perspective 16:49:27 ... RxNORM will give deep coverage, but need ChEbi for small models 16:49:47 charlie: recall that the goal is Phase III clinical trials 16:50:04 ChEbi for molecules that are not yet released 16:50:08 it would be a service if we kept a list of starting points for this. i am interested in participating in this list and also following up 16:50:10 ... so unclear if they'll be diving into {gene,prote}omics at this point 16:50:25 s/goal is Phase III/goal is Phase IV/ 16:51:06 Charlie: Initial focus is Phase IV clinical trials 16:51:18 deborah: what's unique about Phase IV that will affect the ontology? 16:51:23 Deborah: Why Phase IV? 16:51:31 charlie: humans, already passed many hurdles 16:54:47 lol 16:54:52 topic: FHIR 16:56:07 Eric: FHIR is a web-oriented way to represent EMR data 16:57:29 ..Lessons from v3 and RIM is that people don't want to deal with lots of elements and attributes, so FHIR is relatively skinny although there are efforts to map back to RIM. 16:58:03 https://github.com/jmandel/fhir-rdf/tree/master/generic/tests 16:58:13 make to genomics - deborah is also interested in starting points there. i am pulling in some content from some linked data resources there 16:58:38 Mike has joined #HCLS 16:58:57 https://github.com/jmandel/fhir-rdf/blob/master/generated/patient-example-a.ttl 16:59:10 http://www.hl7.org/implement/standards/fhir/resources.html 17:01:26 https://github.com/jmandel/fhir-rdf/tree/master/generated 17:02:59 -Sajjad 17:03:30 i looked up fhir Fast Healthcare Interoperability Resources 17:05:08 Eric: Josh created a tool to generate RDF (ttl) from the XML using the FHIR spec. This gives us a way to compare them and decide where we want them to be different. 17:05:48 Given/If we have OWL version of HL7, what would be the position of FHIR? I mean, in terms of usage. Does OWL version of HL7 would be enough ? 17:06:13 Sorry, I am disconnected from voice, trying to back on 17:08:50 -Mike_Denny 17:09:36 Eric: (interpreting OWL version of HL7 as ORIM) - not practically. If we derive the RDF of FHIR from ORIM, it will be hilariously complex. 17:10:04 .. (Eric was answering Sajjad's question) 17:12:54 trying to connect the conference bridge, but getting the message that the conference is restricted at this time :( 17:13:50 Eric: (his plea for help) We have unit tests for transforms so we would like help with improving the XML2RDF transforms. 17:14:59 i just lost audio 17:16:16 -mscottm 17:16:17 - +1.832.726.aabb 17:16:17 - +33.1.73.71.aacc 17:16:18 -Josh 17:16:18 -stevebattle7 17:16:23 i just tried to call back in and i can not get back in - it says "the conference is restricted at this time" 17:16:36 i would be interested in hearing the rest of the answre after the nih big data call 17:16:38 RRSAgent, please draft minutes 17:16:38 I have made the request to generate http://www.w3.org/2013/11/12-hcls-minutes.html ericP 17:17:00 deborah, i'll scribe it here: 17:17:12 i dunno 17:17:52 in slightly more detail, it'd be practical to go after smallish grants with short review cycles for that work but i don't know where to find them 17:18:31 Sajjad__INSERM_ has left #hcls 17:21:18 disconnecting the lone participant, +1.650.433.aaee, in SW_HCLS()11:00AM 17:21:21 SW_HCLS()11:00AM has ended 17:21:21 Attendees were Kerstin_Forsberg, stevebattle7, +1.413.442.aaaa, +1.832.726.aabb, +33.1.73.71.aacc, Sajjad, +31.62.427.aadd, mscottm, Josh, +1.650.433.aaee, Mike_Denny 17:33:46 egonw__ has joined #HCLS 18:32:11 Zakim has left #hcls 18:55:00 egonw__ has joined #HCLS 19:19:28 mscottm has joined #hcls